`(Table presents the data on ITU Unit Action)
`
`OVERVIEW
`
`SERIAL NUMBER
`
`90455390
`
`FILING DATE
`
`0000000
`
`REG DATE
`
`01/08/2021
`
`N/A
`
`PRINCIPAL
`
`MARK TYPE
`
`TRADEMARK
`
`N/A
`
`INTL REG DATE
`
`TM ATTORNEY
`
`DUBRAY, KATHERINE
`
`L.O. ASSIGNED
`
`PUB INFORMATION
`
`12/02/2024
`
`10/05/2021
`
`734-FIFTH EXTENSION - GRANTED
`
`12/01/2024
`
`ASPARGO
`
`N/A
`
`118
`
`N/A
`
`NO
`
`NO
`
`N/A
`
`N/A
`
`REG NUMBER
`
`REGISTER
`
`INTL REG #
`
`RUN DATE
`
`PUB DATE
`
`STATUS
`
`STATUS DATE
`
`LITERAL MARK
`ELEMENT
`
`DATE ABANDONED
`
`SECTION 2F
`
`SECTION 8
`
`SECTION 15
`
`RENEWAL FILED
`
`DATE AMEND REG
`
`N/A
`
`NO
`
`NO
`
`NO
`
`NO
`
`N/A
`
`DATE CANCELLED
`
`SECTION 2F IN PART
`
`SECTION 8 IN PART
`
`REPUB 12C
`
`RENEWAL DATE
`
`
`
`FILING BASIS
`
`FILED BASIS
`
`CURRENT BASIS
`
`AMENDED BASIS
`
`1 (a)
`
`1 (b)
`
`44D
`
`44E
`
`66A
`
`NO BASIS
`
`NO
`
`YES
`
`NO
`
`NO
`
`NO
`
`NO
`
`1 (a)
`
`1 (b)
`
`44D
`
`44E
`
`66A
`
`NO BASIS
`
`NO
`
`YES
`
`NO
`
`NO
`
`NO
`
`NO
`
`NO
`
`NO
`
`NO
`
`NO
`
`1 (a)
`
`1 (b)
`
`44D
`
`44E
`
`
`
`
`
`MARK DATA
`
`
`
`
`
`
`
`STANDARD CHARACTER MARK
`
`LITERAL MARK ELEMENT
`
`MARK DRAWING CODE
`
`COLOR DRAWING FLAG
`
`YES
`
`ASPARGO
`
`4-STANDARD CHARACTER MARK
`
`NO
`
`CURRENT OWNER INFORMATION
`
`PARTY TYPE
`
`NAME
`
`ADDRESS
`
`ENTITY
`
`CITIZENSHIP
`
`INTERNATIONAL CLASS
`
` DESCRIPTION TEXT
`
`INTERNATIONAL CLASS
`
` DESCRIPTION TEXT
`
`20-OWNER AT PUBLICATION
`
`Aspargo Laboratories, Inc.
`
`550 Sylvan Avenue, Suite 102
`Englewood Cliffs, NJ, 07632
`
`03-CORPORATION
`
`DELAWARE
`
`GOODS AND SERVICES
`
`005
`
`Pharmaceuticals compounds for the treatment of
`erectile dysfunction; sildenafil; oral spray formulation of
`sildenafil; house mark for pharmaceuticals for the
`treatment of erectile dysfunction; medical apparatus,
`namely, a drug delivery device prefilled with
`pharmaceutical products for the treatment of erectile
`dysfunction
`
`010
`
`Pump spray dispensers for medical purposes; oral
`spray device for administering medicament; oral spay
`device for administering sildenafil
`
`GOODS AND SERVICES CLASSIFICATION
`
`INTERNATIONAL
`CLASS
`
`005
`
`FIRST
`USE DATE
`
`NONE
`
`INTERNATIONAL
`CLASS
`
`010
`
`FIRST
`USE DATE
`
`NONE
`
`NONE
`
`CLASS
`STATUS
`
`6-ACTIVE
`
`NONE
`
`CLASS
`STATUS
`
`6-ACTIVE
`
`FIRST USE
`IN
`COMMERCE
`DATE
`
`FIRST USE
`IN
`COMMERCE
`DATE
`
`MISCELLANEOUS INFORMATION/STATEMENTS
`
`CHANGE IN REGISTRATION
`
`NO
`
`
`
`
`
`
`
`
`PROSECUTION HISTORY
`
`ENT CD
`
`ENT
`TYPE
`
`DESCRIPTION
`
`EXRA
`
`EX5G
`
`EXT5
`
`EEXT
`
`EXRA
`
`EXRA
`
`EX4G
`
`EXT4
`
`EEXT
`
`EXRA
`
`DOCK
`
`EX3G
`
`EXT3
`
`EEXT
`
`E
`
`S
`
`S
`
`I
`
`E
`
`E
`
`S
`
`S
`
`I
`
`E
`
`D
`
`S
`
`S
`
`I
`
`NOTICE OF APPROVAL OF EXTENSION REQUEST
`E-MAILED
`
`SOU EXTENSION 5 GRANTED
`
`SOU EXTENSION 5 FILED
`
`SOU TEAS EXTENSION RECEIVED
`
`NOTICE OF APPROVAL OF EXTENSION REQUEST
`E-MAILED
`
`NOTICE OF APPROVAL OF EXTENSION REQUEST
`E-MAILED
`
`SOU EXTENSION 4 GRANTED
`
`SOU EXTENSION 4 FILED
`
`SOU TEAS EXTENSION RECEIVED
`
`NOTICE OF APPROVAL OF EXTENSION REQUEST
`E-MAILED
`
`ASSIGNED TO EXAMINER
`
`SOU EXTENSION 3 GRANTED
`
`SOU EXTENSION 3 FILED
`
`SOU TEAS EXTENSION RECEIVED
`
`ENT
`NUM
`
`048
`
`047
`
`046
`
`045
`
`044
`
`043
`
`042
`
`041
`
`040
`
`039
`
`038
`
`037
`
`036
`
`035
`
`DATE
`
`12/02/2024
`
`12/02/2024
`
`11/26/2024
`
`11/26/2024
`
`06/13/2024
`
`05/31/2024
`
`05/30/2024
`
`05/30/2024
`
`05/30/2024
`
`11/30/2023
`
`11/30/2023
`
`11/29/2023
`
`11/29/2023
`
`11/29/2023
`
`08/10/2023
`
`08/09/2023
`
`05/31/2023
`
`08/09/2023
`
`07/04/2023
`
`07/03/2023
`
`07/03/2023
`
`07/03/2023
`
`07/03/2023
`
`07/03/2023
`
`11/30/2022
`
`11/28/2022
`
`11/28/2022
`
`11/28/2022
`
`05/31/2022
`
`EXRA
`
`EX2G
`
`EXT2
`
`AITU
`
`NREV
`
`TPEX
`
`PETG
`
`PROA
`
`MAB6
`
`ABN6
`
`EXRA
`
`EX1G
`
`EXT1
`
`EEXT
`
`NOAM
`
`E
`
`S
`
`S
`
`A
`
`E
`
`I
`
`O
`
`I
`
`E
`
`S
`
`E
`
`S
`
`S
`
`I
`
`E
`
`NOTICE OF APPROVAL OF EXTENSION REQUEST
`E-MAILED
`
`SOU EXTENSION 2 GRANTED
`
`SOU EXTENSION 2 FILED
`
`CASE ASSIGNED TO INTENT TO USE PARALEGAL
`
`NOTICE OF REVIVAL - E-MAILED
`
`SOU EXTENSION RECEIVED WITH TEAS PETITION
`
`PETITION TO REVIVE-GRANTED
`
`TEAS PETITION TO REVIVE RECEIVED
`
`ABANDONMENT NOTICE E-MAILED - NO USE
`STATEMENT FILED
`
`ABANDONMENT - NO USE STATEMENT FILED
`
`NOTICE OF APPROVAL OF EXTENSION REQUEST
`E-MAILED
`
`SOU EXTENSION 1 GRANTED
`
`SOU EXTENSION 1 FILED
`
`SOU TEAS EXTENSION RECEIVED
`
`NOA E-MAILED - SOU REQUIRED FROM APPLICANT
`
`034
`
`033
`
`032
`
`031
`
`030
`
`029
`
`028
`
`027
`
`026
`
`025
`
`024
`
`023
`
`022
`
`021
`
`020
`
`
`
`
`04/14/2022
`
`03/24/2022
`
`03/23/2022
`
`03/16/2022
`
`11/04/2021
`
`10/05/2021
`
`10/05/2021
`
`09/15/2021
`
`08/27/2021
`
`08/27/2021
`
`08/27/2021
`
`ETOP
`
`CHPB
`
`APET
`
`EPPA
`
`ETOF
`
`NPUB
`
`PUBO
`
`NONP
`
`CNSA
`
`XAEC
`
`GNEN
`
`T
`
`I
`
`A
`
`I
`
`T
`
`E
`
`A
`
`E
`
`P
`
`I
`
`O
`
`EXTENSION OF TIME TO OPPOSE PROCESS -
`TERMINATED
`
`CHANGES/CORRECTIONS AFTER PUB APPROVAL
`ENTERED
`
`ASSIGNED TO PETITION STAFF
`
`TEAS POST PUBLICATION AMENDMENT RECEIVED
`
`EXTENSION OF TIME TO OPPOSE RECEIVED
`
`OFFICIAL GAZETTE PUBLICATION CONFIRMATION
`E-MAILED
`
`PUBLISHED FOR OPPOSITION
`
`NOTIFICATION OF NOTICE OF PUBLICATION E-
`MAILED
`
`APPROVED FOR PUB - PRINCIPAL REGISTER
`
`EXAMINER'S AMENDMENT ENTERED
`
`NOTIFICATION OF EXAMINERS AMENDMENT E-
`MAILED
`
`EXAMINERS AMENDMENT E-MAILED
`
`019
`
`018
`
`017
`
`016
`
`015
`
`014
`
`013
`
`012
`
`011
`
`010
`
`009
`
`008
`
`08/27/2021
`
`08/27/2021
`
`07/28/2021
`
`07/28/2021
`
`07/28/2021
`
`07/19/2021
`
`04/08/2021
`
`GNEA
`
`CNEA
`
`GNRN
`
`GNRT
`
`CNRT
`
`DOCK
`
`NWOS
`
`01/12/2021
`
`NWAP
`
`O
`
`R
`
`O
`
`F
`
`R
`
`D
`
`I
`
`I
`
`EXAMINERS AMENDMENT -WRITTEN
`
`NOTIFICATION OF NON-FINAL ACTION E-MAILED
`
`NON-FINAL ACTION E-MAILED
`
`NON-FINAL ACTION WRITTEN
`
`ASSIGNED TO EXAMINER
`
`NEW APPLICATION OFFICE SUPPLIED DATA
`ENTERED
`
`NEW APPLICATION ENTERED
`
`007
`
`006
`
`005
`
`004
`
`003
`
`002
`
`001
`
`CURRENT CORRESPONDENCE INFORMATION
`
`ATTORNEY
`
`CORRESPONDENCE ADDRESS
`
`Anthony E. Bennett
`
`Anthony E. Bennett
`HOFFMANN & BARON LLP
`6900 JERICHO TURNPIKE
`SYOSSET, NY, 11791
`
`DOMESTIC REPRESENTATIVE
`
`NONE
`
`PRIOR OWNER INFORMATION
`
`PARTY TYPE
`
`NAME
`
`ADDRESS
`
`ENTITY
`
`CITIZENSHIP
`
`10-ORIGINAL APPLICANT
`
`Aspargo Laboratories, Inc.
`
`550 Sylvan Avenue, Suite 102
`Englewood Cliffs, NJ 07632
`
`03-CORPORATION
`
`DELAWARE
`
`
`
`
`
`
`
`ASPARGO
`
`